(Q35588125)

9 August 2017

1 reference

title

Current therapy and new molecular approaches to antiviral treatment and prevention of hepatitis C. (English)

1 reference

9 August 2017

Thomas Hügle

1

1 reference

PubMed ID

14625884

9 August 2017

Andreas Cerny

series ordinal

2

1 reference

9 August 2017

1 November 2003

1 reference

Reviews in Medical Virology

9 August 2017

1 reference

9 August 2017

13

1 reference

9 August 2017

361-371

1 reference

9 August 2017

6

1 reference

Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex

9 August 2017

1 reference

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

21 January 2018

1 reference

Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase

21 January 2018

1 reference

Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site

21 January 2018

1 reference

Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA

21 January 2018

1 reference

Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins

21 January 2018

1 reference

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

21 January 2018

1 reference

Hepatitis C virus replication in mice with chimeric human livers

21 January 2018

1 reference

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

21 January 2018

1 reference

Analysis of successful immune responses in persons infected with hepatitis C virus

21 January 2018

1 reference

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

21 January 2018

1 reference

Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children

21 January 2018

1 reference

Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence.

21 January 2018

1 reference

Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition

21 January 2018

1 reference

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis

21 January 2018

1 reference

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

Peginterferon alfa-2a in patients with chronic hepatitis C.

21 January 2018

1 reference

Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy.

21 January 2018

1 reference

NMR line-broadening and transferred NOESY as a medicinal chemistry tool for studying inhibitors of the hepatitis C virus NS3 protease domain

21 January 2018

1 reference

Non-nucleoside analogue inhibitors bind to an allosteric site on HCV NS5B polymerase. Crystal structures and mechanism of inhibition

21 January 2018

1 reference

Short interfering RNA confers intracellular antiviral immunity in human cells

21 January 2018

1 reference

Modulation of HIV-1 replication by RNA interference

21 January 2018

1 reference

Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs

21 January 2018

1 reference

Small Interfering RNA-Mediated Inhibition of Hepatitis C Virus Replication in the Human Hepatoma Cell Line Huh-7

21 January 2018

1 reference

Functional properties of a monoclonal antibody inhibiting the hepatitis C virus RNA-dependent RNA polymerase

21 January 2018

1 reference

Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience

21 January 2018

1 reference

Thymosin alpha1 accelerates restoration of T cell-mediated neutralizing antibody response in immunocompromised hosts

21 January 2018

1 reference

Lack of antiviral effect of a short course of mycophenolate mofetil in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8.

21 January 2018

1 reference

Triple antiviral therapy as a new option for patients with interferon nonresponsive chronic hepatitis C.

21 January 2018

1 reference

Perspectives: towards a peptide-based vaccine against hepatitis C virus.

21 January 2018

1 reference

DNA-based vaccination against hepatitis C virus (HCV): effect of expressing different forms of HCV E2 protein and use of CpG-optimized vectors in mice

21 January 2018

1 reference

In vitro studies of core peptide-bearing immunopotentiating reconstituted influenza virosomes as a non-live prototype vaccine against hepatitis C virus

21 January 2018

1 reference

DNA-based immunotherapy: potential for treatment of chronic viral hepatitis?

21 January 2018

1 reference

Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens.

21 January 2018

1 reference

Different hepatitis C virus nonstructural protein 3 (Ns3)-DNA-expressing vaccines induce in HLA-A2.1 transgenic mice stable cytotoxic T lymphocytes that target one major epitope

21 January 2018

1 reference

Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs

21 January 2018

1 reference

A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

A proposed system for the nomenclature of hepatitis C viral genotypes

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/RMV.397

1 reference

9 August 2017

1 reference

PubMed ID

14625884